#MD Pulmonary Medicine

[covid-safer-hotties]

Patients With Long-COVID Show Abnormal Lung Perfusion Despite Normal CT Scans - Published Sept 12, 2024

VIENNA — Some patients who had mild COVID-19 infection during the first wave of the pandemic and continued to experience postinfection symptoms for at least 12 months after infection present abnormal perfusion despite showing normal CT scans. Researchers at the European Respiratory Society (ERS) 2024 International Congress called for more research to be done in this space to understand the underlying mechanism of the abnormalities observed and to find possible treatment options for this cohort of patients.

Laura Price, MD, PhD, a consultant respiratory physician at Royal Brompton Hospital and an honorary clinical senior lecturer at Imperial College London, London, told Medscape Medical News that this cohort of patients shows symptoms that seem to correlate with a pulmonary microangiopathy phenotype.

"Our clinics in the UK and around the world are full of people with long-COVID, persisting breathlessness, and fatigue. But it has been hard for people to put the finger on why patients experience these symptoms still," Timothy Hinks, associate professor and Wellcome Trust Career Development fellow at the Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre senior research fellow, and honorary consultant at Oxford Special Airway Service at Oxford University Hospitals, England, who was not involved in the study, told Medscape Medical News.

The Study Researchers at Imperial College London recruited 41 patients who experienced persistent post-COVID-19 infection symptoms, such as breathlessness and fatigue, but normal CT scans after a mild COVID-19 infection that did not require hospitalization. Those with pulmonary emboli or interstitial lung disease were excluded. The cohort was predominantly female (87.8%) and nonsmokers (85%), with a mean age of 44.7 years. They were assessed over 1 year after the initial infection.

Exercise intolerance was the predominant symptom, affecting 95.1% of the group. A significant proportion (46.3%) presented with myopericarditis, while a smaller subset (n = 5) exhibited dysautonomia. Echocardiography did not reveal pulmonary hypertension. Laboratory findings showed elevated angiotensin-converting enzyme and antiphospholipid antibodies. "These patients are young, female, nonsmokers, and previously healthy. This is not what you would expect to see," Price said. Baseline pulmonary function tests showed preserved spirometry with forced expiratory volume in 1 second and forced vital capacity above 100% predicted. However, diffusion capacity was impaired, with a mean diffusing capacity of the lungs for carbon monoxide (DLCO) of 74.7%. The carbon monoxide transfer coefficient (KCO) and alveolar volume were also mildly reduced. Oxygen saturation was within normal limits.

These abnormalities were through advanced imaging techniques like dual-energy CT scans and ventilation-perfusion scans. These tests revealed a non-segmental and "patchy" perfusion abnormality in the upper lungs, suggesting that the problem was vascular, Price explained.

Cardiopulmonary exercise testing revealed further abnormalities in 41% of patients. Peak oxygen uptake was slightly reduced, and a significant proportion of patients showed elevated alveolar-arterial gradient and dead space ventilation during peak exercise, suggesting a ventilation-perfusion mismatch.

Over time, there was a statistically significant improvement in DLCO, from 70.4% to 74.4%, suggesting some degree of recovery in lung function. However, DLCO values did not return to normal. The KCO also improved from 71.9% to 74.4%, though this change did not reach statistical significance. Most patients (n = 26) were treated with apixaban, potentially contributing to the observed improvement in gas transfer parameters, Price said.

The researchers identified a distinct phenotype of patients with persistent post-COVID-19 infection symptoms characterized by abnormal lung perfusion and reduced gas diffusion capacity, even when CT scans appear normal. Price explains that this pulmonary microangiopathy may explain the persistent symptoms. However, questions remain about the underlying mechanisms, potential treatments, and long-term outcomes for this patient population.

Causes and Treatments Remain a Mystery Previous studies have suggested that COVID-19 causes endothelial dysfunction, which could affect the small blood vessels in the lungs. Other viral infections, such as HIV, have also been shown to cause endothelial dysfunction. However, researchers don't fully understand how this process plays out in patients with COVID-19.

"It is possible these patients have had inflammation insults that have damaged the pulmonary vascular endothelium, which predisposes them to either clotting at a microscopic level or ongoing inflammation," said Hinks.

Some patients (10 out of 41) in the cohort studied by the Imperial College London's researchers presented with Raynaud syndrome, which might suggest a physiological link, Hinks explains. "Raynaud's is a condition of vascular control or dysregulation, and potentially, there could be a common factor contributing to both breathlessness and Raynaud's."

He said there is an encouraging signal that these patients improve over time, but their recovery might be more complex and lengthy than for other patients. "This cohort will gradually get better. But it raises questions and gives a point that there is a true physiological deficit in some people with long-COVID."

Price encouraged physicians to look beyond conventional diagnostic tools when visiting a patient whose CT scan looks normal yet experiences fatigue and breathlessness. Not knowing what causes the abnormalities observed in this group of patients makes treatment extremely challenging. "We need more research to understand the treatment implications and long-term impact of these pulmonary vascular abnormalities in patients with long-COVID," Price concluded.

[bpod-bpod]

ROS vs Bacteria

Inducing lung lining cells to produce bacteria-killing reactive oxygen species (highly reactive chemicals that can cause oxidative damage) protects against pneumonia without reliance on antibiotics

Read the published research paper here

Image from work by Yongxing Wang and colleagues

Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Image originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)

Published in PLOS Pathogens, September 2023

You can also follow BPoD on Instagram, Twitter and Facebook

[thehealthfirstcenter]

The Best General Physician in Delhi: Dr. Sanchayan Roy

When it comes to managing your health, having a trusted and experienced General Physician in Delhi is crucial. For residents of Delhi, Dr. Sanchayan Roy has established himself as a leading name in the field of general medicine. Renowned for his expertise, compassionate approach, and patient-focused care, Dr. Sanchayan Roy is widely regarded as the Best General Physician in Delhi.

Who is Dr. Sanchayan Roy?

Dr. Sanchayan Roy is a highly qualified and experienced general physician based in Delhi. With a career spanning over two decades, he has built a reputation for delivering exceptional healthcare services. Dr. Roy’s qualifications include:

MBBS and MD in Internal Medicine

Advanced certifications in pulmonology and diabetes management

Numerous accolades for excellence in patient care

His clinic is equipped with state-of-the-art facilities, ensuring accurate diagnoses and effective treatments for a wide range of medical conditions.

Comprehensive Medical Expertise

One of the reasons Dr. Sanchayan Roy is considered the Best General Physician Near Meis his extensive knowledge and skill in managing a variety of health concerns. His areas of expertise include:

1. Diabetes Management

As a certified diabetes specialist, Dr. Roy provides comprehensive care for patients dealing with this chronic condition. He focuses on creating personalized treatment plans that include medication, lifestyle modifications, and dietary recommendations.

2. Pulmonology Services

Dr. Roy is also known for his expertise in pulmonary medicine. Whether it’s asthma, chronic obstructive pulmonary disease (COPD), or respiratory infections, he ensures accurate diagnoses and effective treatments.

3. Preventive Healthcare

Prevention is better than cure, and Dr. Roy emphasizes preventive healthcare. He offers regular health check-ups, vaccination advice, and screenings to help patients stay ahead of potential health issues.

4. Chronic Disease Management

From hypertension to thyroid disorders, Dr. Roy has a proven track record in managing chronic illnesses, helping patients lead healthier lives.

Why Choose Dr. Sanchayan Roy?

1. Patient-Centric Approach

Dr. Roy is deeply committed to patient care. He takes the time to understand each patient’s unique medical history and concerns, ensuring that they feel heard and valued.

2. Advanced Diagnostic Tools

His clinic is equipped with the latest medical technologies, enabling precise and timely diagnoses. This commitment to innovation sets him apart from other general physicians in Delhi.

3. Personalized Treatment Plans

No two patients are the same, and Dr. Roy understands this well. His treatment plans are tailored to each individual’s needs, ensuring optimal health outcomes.

4. Holistic Care

Dr. Roy believes in treating not just the symptoms but the root cause of health issues. His holistic approach focuses on physical, mental, and emotional well-being.

Convenient Location and Flexible Appointments

Dr. Sanchayan Roy’s clinic is conveniently located in the heart of Delhi, making it accessible for residents across the city. He also offers flexible appointment schedules, including online consultations, ensuring that patients can receive care at their convenience.

How to Book an Appointment with Dr. Sanchayan Roy

Booking an appointment with the Best General Physician in Delhi is easy. You can contact his clinic directly or book an online consultation through his website. Whether you need a routine check-up or specialized care, Dr. Roy is here to help.

Conclusion

For those seeking top-notch medical care in Delhi, Dr. Sanchayan Roy is the go-to general physician. His unparalleled expertise, patient-focused approach, and commitment to excellence make him the Best General Physician in South Delhi. Don’t compromise on your health—choose a physician you can trust.

Get more information:

Name: Dr. Sanchayan Roy

Phone No.: 7838384440

Address: B - 404, Lower Ground Floor, Market No 1, Bipin Chandra Pal Marg, next to Bangiya Samaj close to, Block B, Chittaranjan Park, New Delhi - 110019

Website: https://healthfirstcenter.in/

Direction: https://maps.app.goo.gl/VW7PqGovVpt8yRJEA

[txhospitals12345]

Best Lungs Specialists in Hyderabad -TX Hospitals

Lung health is vital to overall well-being, and when you experience breathing difficulties, chest pain, or chronic respiratory issues, consulting a specialized lung doctor becomes essential. In Hyderabad, there are numerous well-trained and experienced lungs specialists who are experts in treating a wide array of respiratory conditions. Whether you are dealing with asthma, chronic obstructive pulmonary disease (COPD), tuberculosis, or even lung cancer, a lung specialist can help provide the right diagnosis and treatment plan. At TX Hospitals, we are proud to offer the best care with some of the leading lungs specialists in the city.

Why Consult a Lungs Specialist?

If you experience symptoms like persistent coughing, shortness of breath, wheezing, chest pain, or frequent respiratory infections, it’s important to consult a lung specialist as soon as possible. Lungs specialists (pulmonologists) focus on diagnosing and treating diseases related to the lungs and respiratory system. Early consultation ensures prompt treatment and can prevent the development of more severe conditions. By managing symptoms and treating underlying issues, a pulmonologist helps improve your quality of life and lung function.

Top Lungs Specialists at TX Hospitals in Hyderabad

TX Hospitals in Hyderabad offers the best lung care services with experienced pulmonologists who specialize in treating a range of lung diseases. Here are some of the top lungs specialists at TX Hospitals:

1. Dr. M.V. Sree Keerthi – Best Lungs Specialist

Dr. M.V. Sree Keerthi is one of the most renowned lungs specialists in Hyderabad. With his qualifications in MBBS, DNB, and DTCD (Pulmonology), he brings years of experience in diagnosing and treating complex lung conditions. His specialties include the management of asthma, COPD, tuberculosis, sleep apnea, and interstitial lung diseases. Dr. Sree Keerthi is highly regarded for his patient-centered approach, ensuring that each patient receives personalized care and attention. His treatments focus on not just managing symptoms, but improving overall lung health for the long term.

2. Dr. Sathish Pogula – Chest Specialist & Lungs Expert

Dr. Sathish Pogula is a distinguished chest specialist and lungs expert at TX Hospitals. He holds an MBBS, MD, and IDCCM and has years of experience in treating lung-related ailments. Dr. Pogula is known for his thorough diagnostic skills, using advanced medical technologies to understand the root causes of respiratory issues. His approach to treatment involves both medical therapy and lifestyle changes that promote lung health. Whether dealing with chronic conditions like asthma or acute respiratory distress, Dr. Pogula offers a wide range of services to ensure effective treatment.

3. Dr. Naresh Dude – Pulmonologist

Dr. Naresh Dude is a highly respected pulmonologist in Hyderabad, known for his expertise in treating severe and complex lung diseases. He holds an MBBS, DNB, and FCCM and specializes in critical care and intensive pulmonary medicine. Dr. Dude’s approach to care focuses on early diagnosis, proper management, and innovative treatments to tackle lung diseases such as pneumonia, pulmonary fibrosis, and lung infections. His extensive experience in handling critical lung conditions makes him one of the best pulmonologists in Hyderabad.

4. Dr. Rohith Reddy – Lungs Specialist

Dr. Rohith Reddy is another excellent lungs specialist at TX Hospitals. He holds an MBBS and MD in Pulmonary Medicine. With a passion for diagnosing and treating respiratory diseases, Dr. Reddy provides comprehensive care for conditions such as COPD, asthma, lung infections, and other chronic pulmonary diseases. His extensive knowledge, along with his compassionate approach, makes him a trusted name among patients seeking care for lung diseases in Hyderabad.

Why Choose TX Hospitals for Lung Care?

TX Hospitals is a leading healthcare provider in Hyderabad, offering state-of-the-art facilities and world-class medical care in pulmonology. The hospital is known for its experienced doctors, advanced diagnostic tools, and holistic approach to treatment. Whether it's for routine check-ups or the treatment of complex lung conditions, TX Hospitals offers a patient-friendly environment with a team of pulmonologists who are experts in their field.

At TX Hospitals, we use the latest technologies, such as advanced imaging and diagnostic tools, to provide accurate diagnoses and effective treatment plans. Our specialists are committed to helping patients manage their respiratory conditions, improving their lung health, and preventing further complications. Whether it’s asthma, chronic cough, difficulty breathing, or any other pulmonary issue, TX Hospitals is the place to go for expert care.

Contact Information

If you or a loved one is experiencing respiratory issues, it’s important to seek professional care as soon as possible. TX Hospitals in Hyderabad is home to some of the best lungs specialists who can help diagnose and treat lung diseases. For consultations and appointments, contact TX Hospitals at 9089489089. Our team is here to provide the highest level of care to ensure that your lung health is in the best hands.

This content offers an overview of the best lungs specialists in Hyderabad, specifically highlighting the expertise available at TX Hospitals. Let me know if you need any modifications or additional information!

[myrawjcsmicasereports]

 Resolution of QRS-fragmentation: A case report and review of literature by Zhong Yi, MD in Journal of Clinical Case Reports Medical Images and Health Sciences

Abstract

Background: It’s not clear whether the resolution of fQRS can be used to assess the effectiveness of cardiac resynchronization therapy defibrillator (CRT-D) in patients of heart failure with reduced ejection fraction (HFrEF).

Case presentation: Here we report a 78-year-old male patient with HFrEF and refractory ventricular tachycardia (VT), who’s 12-lead electrocardiogram (ECG) showed fQRS in leads V1-V6 with QRS duration of 134 ms on admission. Even though the optimized medication of metoprolol, amiodarone, lidocaine, and berberine was given, the recurrent VT and HFrEF were still refractory. For further management, a CRT-D with multipoint pacing (MPP) function (St. Jude Medical, Sylmar, CA) was considered and implanted. It’s very encouraging that no more VTs and fQRS were recorded 9 hours after a CRT-D with MPP function was implanted, and the left ventricle ejection fraction (LVEF) improved significantly later.

Conclusion: CRT-D with MPP is effective in improving the situation of the patient with ischemic cardiomyopathy and HFrEF, and the fQRS resolution can be considered as a sign of its effectiveness.

Keywords: Fragmented QRS; Heart failure; Cardiac resynchronization therapy; Multipoint pacing

Introduction

Fragmented QRS (fQRS) on the 12-lead electrocardiogram (ECG) is defined as the presence of additional notches buried within the QRS, which is widely accepted as a sign of myocardial infarction scar or fibrosis. [1, 2] The fQRS is derived from the abnormality of ventricular depolarization due to ventricular heterogeneity and derangement of ventricular conduction around the infarction zone or scar. [3-5]  And the fQRS is also a sign of left ventricular desynchronization in patients of heart failure with reduced ejection fraction (HFrEF) and the narrow QRS complex (<150 ms). [6] A meta-analysis showed that fQRS on patient’s baseline ECG increased all-cause mortality and major arrhythmic events in HFrEF patients. [7] However, it’s not clear whether the resolution of fQRS is useful to assess the effectiveness of cardiac resynchronization therapy defibrillator (CRT-D) in patients with ischemic cardiomyopathy, especially those CRT-D with multipoint pacing (MPP) function. Here we present an HFrEF patient who had fQRS on his admission ECG and frequent ventricular tachycardia (VT) on his Ambulatory ECG. But no more VT and fQRS were recorded, 9 hours after the implantation of a CRT-D with MPP function. The patient had provided informed consent for publication of this case.

Case presentation

A 78-year-old man presented with a complaint of chest congestion and short of breath lasted for 2 hours on his admission. He had hypertension for 10 years, but his blood pressure was normal on admission without taking any medicine. He had an old myocardial infarction and a coronary artery stent implanted 18 years before, and 2 more stents implanted 10 years before. The patient took a semi-sitting position, the blood pressure was 105/65 mmHg, and the heart rate was 80 bpm. Both lungs were clear, the apex was left out of the normal limit, and slight edema in lower extremities was found. His laboratory examination, including blood routine, hepatic and renal function, electrolyte, coagulation function, and Cardiac troponin I (CTNI), was normal, but the level of brain natriuretic peptide (BNP) elevated to 3082 pg/ml. The ECG showed sinus rhythm, ventricular bigeminy, fQRS in leads V1-V6, QRS duration of 134 ms, and abnormal Q wave in leads V4-V6 (Fig. 1a). His 24-hours Holter monitoring showed 41,320 polymorphic ventricular premature beats (PVCs), which is 42% of the total 98327 beats, and 254 paroxysmal polymorphic VT (Fig. 2a). His chest x-radiography revealed pulmonary congestion, pear-shaped heart and cardio-thoracic proportion of more than 50% (Fig. 3a). His transthoracic echocardiography showed left atrium and ventricle enlargement with the left ventricular end-diastolic diameter of 62 mm; there was a ventricular aneurysm of 5.2×2.0 cm2; there was minor regurgitation of mitral and aortic valves; the left ventricular ejection fraction (LVEF) was 28%. Moreover, no coronary artery or stent stenosis was shown by coronary angiography. We proposed the patient’s primary diagnosis was ischemic cardiomyopathy and HFrEF. Even though the optimized medication of metoprolol, amiodarone, lidocaine, and berberine was given, the recurrent VT and HFrEF were still refractory. For further management, a CRT-D with MPP function (St. Jude Medical, Sylmar, CA) was considered and implanted. It’s very encouraging that 9 hours after the procedure, no VT was monitored again (Fig. 2b); twenty-four hours later, the fQRS was absent and never been recorded after that, and the QRS duration decreased from 134 ms to 122 ms (Fig. 1b). Also, the level of BNP significantly dropped to 357 pg/ml. Furthermore, nine days after the procedure, the LVEF increased to 45%; 30 days later, no pulmonary congestion was found on his Chest x-radiography and the cardio-thoracic proportion improved significantly (Fig. 3b). While, over one year of follow-up, the patient has remained symptom-free of VT and HF.

The patient’s chest x-radiography revealed pulmonary congestion, pear-shaped heart, and cardio-thoracic proportion more than 50% at baseline; (b) There was no pulmonary congestion, and the cardio-thoracic percentage decreased significantly, 30 days after the CRT-D implantation.

Discussion

Considering this patient’s old MI history, we supposed that the possible reason for short of breath on admission was acute myocardial ischemia or acute heart failure. But there was no coronary artery or stent stenosis on his coronary angiography, and the level of CTNI was normal. Combined with clinical signs, chest x-radiography, echocardiographic signs, and elevated levels of BNP, the reason for short of breath was sure to be acute heart failure.

The fQRS is defined as various ‘RSR’ patterns, with or without a Q wave, located in two contiguous leads of a major coronary artery territory. And, the fQRS manifests as an extra R (R’) wave, ≥2 notches in R wave, or ≥2 notches in the down or up-stroke of S wave.[4] It’s reported that fQRS was associated with myocardial infarction scar or fibrosis, and was considered as a sign of old myocardial infarction. [1, 2] The fQRS was also considered as a marker of left ventricular dyssynchrony in HFrEF patients with narrow QRS complex (<150ms). [6] Furthermore, the fQRS was also associated with higher all-cause mortality, and cardiac event rate defined as MI, need for revascularization, VT and cardiac death. [8, 9] The fQRS found in contiguous 3 leads was a significant predictor of the cardiac death or heart failure hospitalization. [9] fQRS increased MAE in HFrEF patients. [7] In this HFrEF patient, the fQRS, with narrow QRS complex of 134 ms, presented on all the 6 precordial leads (V1-V6) on his admission ECG. As it was discussed on the above, the presence of fQRS, with narrow QRS complex on the ECG, was showed that he had left ventricular dyssynchrony caused by myocardial infarction scar or fibrosis. Therefore, our strategy focused on improving the ischemic cardiomyopathy induced HFrEF, and CRT-D with MPP was the best choice for the management of his refractory VT and HFrEF. Practically, the complete resolution of fQRS accompanied by the improvement of HFrEF in a relatively short hospital stay is strong evidence support for the effectiveness of CRT-D with MPP function.

Implantable CRT with MPP is a new quadripolar technology that involves a left ventricle lead with 4 different pacing electrodes and a dedicated device with multiple pacing options. [9] MPP is superior to the conventional biventricular pacing on the improvement of acute cardiac hemodynamics, left ventricle synchronization, and QRS complex narrowing, and all of this manifested as a higher number of acute responders to CRT. [10-12] Therefore, a CRT-D with MPP was implanted in our patient. Then, he had a significant improvement, such as the termination of VT, the narrowing of QRS, the elevation of LVEF, and the relief of HF symptoms.

In conclusion, CRT-D with MPP is very useful in improving the LVEF of the patient with ischemic cardiomyopathy and HFrEF. And the resolution of fQRS may be a sign of the alleviation of HFrEF by using CRT-D with MPP.

[muskanhealthcareblogger]

Who Is Eligible for a Fellowship in Critical Care?

A fellowship in critical care medicine is a specialized training program designed for healthcare professionals aiming to become experts in managing critically ill patients. This advanced training focuses on diagnosing, monitoring, and treating life-threatening conditions that require intensive care. But who is eligible for a critical care fellowship? Let’s explore the requirements and pathways.

What Is a Critical Care Fellowship?

A critical care fellowship equips physicians with the skills needed to handle complex medical emergencies, including multi-organ failure, sepsis, trauma, and post-operative care. Fellowships are typically offered in disciplines such as internal medicine, anesthesia, surgery, or emergency medicine, with training often spanning 1-2 years.

General Eligibility Criteria for a Critical Care Fellowship

To qualify for a critical care fellowship, candidates must meet specific educational and professional prerequisites, which can vary depending on the country and institution. However, the general requirements include:

1. Completion of a Medical Degree

Candidates must hold a recognized medical degree (MD, DO, MBBS, or equivalent).

Graduates from international medical schools may need to pass qualifying exams like the USMLE (United States) or PLAB (UK) to demonstrate eligibility.

2. Residency Training

Fellowship applicants must complete a residency program in a related specialty. Common pathways include:

Internal Medicine: Often followed by a pulmonary-critical care combined fellowship.

Anesthesiology: A route for those focusing on perioperative and critical care management.

Emergency Medicine: Ideal for physicians managing acute, life-threatening emergencies.

Surgery: Specialized critical care fellowships cater to post-surgical intensive care.

3. Board Certification (or Eligibility)

Most programs require candidates to be board-certified or board-eligible in their primary specialty. This ensures a foundational knowledge base and clinical expertise.

4. Licensing Requirements

A valid medical license to practice in the country or state where the fellowship is offered is typically mandatory.

5. Other Selection Criteria

Strong letters of recommendation from mentors or program directors.

Evidence of clinical experience, research, or academic achievements in critical care-related areas.

A personal statement highlighting the candidate's motivation, career goals, and commitment to the specialty.

Specialized Tracks and Subspecialties

Critical care fellowships are diverse and may focus on specific patient populations or medical conditions. Examples include:

Neurocritical Care: Specializing in critically ill neurological and neurosurgical patients.

Pediatric Critical Care: Focused on the intensive care of children.

Cardiothoracic Critical Care: For managing post-cardiac surgery patients or severe cardiac conditions.

Trauma Critical Care: Designed for surgeons or emergency medicine physicians focusing on trauma-related emergencies.

Application Process

The application process typically includes submitting credentials, passing interviews, and ranking programs through matching services like the National Resident Matching Program (NRMP) for U.S.-based fellowships. International candidates may also need visas and additional qualifications.

Why Pursue a Critical Care Fellowship?

The demand for skilled intensivists is growing globally, making this a rewarding career choice for physicians passionate about saving lives in high-stakes environments. Critical care fellows gain access to advanced training, cutting-edge technology, and opportunities to contribute to research and education.

Conclusion

Eligibility for a fellowship in critical care depends on a strong foundation in medicine, completion of relevant residency training, and a passion for managing critically ill patients. By meeting these criteria and demonstrating a commitment to excellence, aspiring intensivists can embark on a fulfilling career in one of the most dynamic fields of medicine.

For specific details, consult the program guidelines of the institution or region where you wish to apply.

[txhospitals1234]

Pneumonia Specialists in Hyderabad: Expert Care for Your Respiratory Health

Pneumonia is a serious respiratory condition that affects millions of people each year. It occurs when the air sacs in the lungs become inflamed, often due to an infection. Pneumonia can cause severe breathing difficulties, fever, and fatigue, and in some cases, it can be life-threatening. Early diagnosis and treatment are crucial for managing pneumonia effectively and preventing complications.

If you or a loved one is suffering from pneumonia or showing symptoms such as persistent cough, chest pain, shortness of breath, or fever, seeking the help of a qualified pneumonia specialist is essential. Hyderabad is home to several top pulmonologists and pneumonia specialists who provide expert care and ensure that patients receive the best treatment options.

At TX Hospitals, we have a team of experienced specialists who are highly skilled in diagnosing and treating pneumonia. Our pulmonologists use advanced diagnostic tools and treatment protocols to offer personalized care for every patient.

1. Dr. Sathish Pogula – Experienced Pneumonia Specialist

Dr. Sathish Pogula is a highly respected chest and pneumonia specialist in Hyderabad. With an MBBS, MD, and IDCCM qualification, Dr. Pogula has extensive experience in treating respiratory conditions, including pneumonia. His expertise in critical care medicine allows him to handle even the most severe cases of pneumonia, ensuring that patients receive timely and effective treatment.

Dr. Pogula uses advanced diagnostic methods such as chest X-rays, CT scans, and blood tests to determine the exact cause of pneumonia and create a tailored treatment plan. Whether it's bacterial, viral, or fungal pneumonia, Dr. Pogula ensures that every patient receives the right medication and support to recover swiftly.

2. Dr. Naresh Dude – Renowned Pulmonologist and Pneumonia Expert

Dr. Naresh Dude, with his MBBS, DNB, and FCCM certifications, is one of the leading pulmonologists in Hyderabad. Specializing in pulmonary medicine and critical care, Dr. Dude has vast experience in diagnosing and treating pneumonia, especially in severe or complicated cases. His thorough approach to patient care and his use of the latest medical technology ensure that patients receive the best possible outcomes.

Dr. Dude’s expertise in managing pneumonia in high-risk patients, such as the elderly, immunocompromised individuals, and those with chronic conditions, makes him one of the top choices for pneumonia treatment in Hyderabad. His compassionate care and dedication to improving his patients' quality of life have earned him a stellar reputation.

3. Dr. Rohith Reddy – Pulmonary Medicine Specialist

Dr. Rohith Reddy, an MBBS graduate with an MD in Pulmonary Medicine, is known for his expertise in treating various respiratory conditions, including pneumonia. Dr. Reddy takes a holistic approach to patient care, addressing not only the pneumonia itself but also the underlying conditions that may contribute to its development, such as asthma, COPD, or heart disease.

His patient-centered approach ensures that treatment plans are customized to each patient’s unique needs, helping them recover quickly and prevent future respiratory infections. Dr. Reddy's vast experience and knowledge make him one of the top pneumonia specialists in Hyderabad.

4. Dr. M.V. Sree Keerthi – Specialist in Pulmonary and Respiratory Care

Dr. M.V. Sree Keerthi is a highly skilled pulmonologist specializing in treating pneumonia and other respiratory conditions. With an MBBS, DNB, and DTCD in Pulmonary Medicine, Dr. Keerthi has extensive training in managing both uncomplicated and complex pneumonia cases.

Dr. Keerthi uses a combination of medical interventions, including antibiotics, antivirals, and antifungals, as well as respiratory therapies, to treat pneumonia. She is also skilled in managing pneumonia-related complications such as respiratory failure or pleural effusion, ensuring comprehensive care for her patients.

Why Choose TX Hospitals for Pneumonia Treatment?

TX Hospitals is equipped with state-of-the-art facilities and a team of highly skilled pneumonia specialists who offer advanced care for patients suffering from respiratory conditions. Our hospital offers a wide range of diagnostic tools, including digital X-rays, CT scans, and pulmonary function tests, to accurately diagnose pneumonia and determine its cause.

Services at TX Hospitals:

Comprehensive Pneumonia Diagnosis: We offer advanced diagnostic tests, such as blood tests, chest X-rays, and sputum cultures, to identify the type and cause of pneumonia.

Personalized Treatment Plans: Based on the diagnosis, our specialists create customized treatment plans, including antibiotics, antivirals, and antifungals, along with respiratory support if necessary.

Critical Care: For severe cases of pneumonia, we offer intensive care services, including mechanical ventilation and monitoring, to support respiratory function.

Pulmonary Rehabilitation: We provide rehabilitation programs to help patients recover and regain their lung function after an illness like pneumonia.

Book an Appointment Today

If you or a loved one is suffering from pneumonia, don't wait for symptoms to worsen. Book an appointment with one of our expert pneumonia specialists at TX Hospitals today. Our team is committed to providing timely, effective, and compassionate care to help you recover quickly.

For appointments, call 9089 48 9089. Our team at TX Hospitals is here to help you breathe easier and get back to a healthy, active life.

At TX Hospitals, we are committed to providing the highest quality care for all respiratory conditions, including pneumonia. With our experienced specialists and advanced treatment options, we ensure that every patient receives the care they need for a full recovery.

[phawareglobal]

John Kingrey, MD and Nicole Fitzgerald - phaware® interview 493

John Kingrey, MD, director of the INTEGRIS Pulmonary Hypertension (PH) center of Oklahoma and PH patient, Nicole Fitzgerald, discuss the importance of the physician-patient relationship as it relates to participation in clinical trials including the Phase 2 TORREY Study (now the Phase 3 PROSERA Study). #GossamerBioPartner #sponsored

John Kingrey, MD: My name is John Kingrey. I’m the director of the Pulmonary Hypertension Center at INTEGRIS Health. I’m a pulmonologist in pulmonary hypertension in Oklahoma City. I’ve been involved in pulmonary hypertension starting in the early part of my medical training, and I chose to pursue pulmonary hypertension as a subspecialty within pulmonary medicine and have been doing that ever since.

Nicole Fitzgerald: My name is Nicole Fitzgerald. I am 44 years old and I am a pulmonary hypertension patient. I’m originally from Los Angeles, but I currently live in Oklahoma City, where I have lived for the past six years.

John Kingrey, MD: Today, we’re going to discuss the importance of the physician-patient relationship as it relates to participation in clinical trials. Clinical trials are an essential part of most fields of medicine, but particularly pulmonary hypertension at this time, because there is so much development of new pathways and new agents that can potentially change the landscape of the disease. 

At our pulmonary hypertension center, we have typically multiple clinical trials going on at one time. The nature of each clinical trial is a little bit different, and the population that we are investigating is also different, but it’s all centered around patients with pulmonary hypertension. However, it’s really important to understand that clinical trials have a very focused population for which they’re interested in, because they’re trying to investigate whether or not a certain product or a certain device could be effective in this specific disease state that they think that it will work in.

Each patient that comes in, in some way, either formally or informally is considered for clinical trials. We know as a center, what our current clinical trial profile looks like and the specific population that could be potential candidates. When I’m in a clinic visit with a patient, I am thinking about what we have potentially to offer them and whether or not they would be a candidate. For a lot of our patients, I know that because of either how long they’ve had the disease or the specific nature of their disease and its severity, they may not be a clinical trial candidate, so it’s not really brought up in many patient encounters. 

However, when I have a patient that I think may fit one of our clinical trials and I think, more importantly, that it would be a good opportunity that would be of benefit to the patient, then that’s when I will bring that up, usually as part of a typical clinic encounter. Sometimes, depending on the clinical trial, we will have a special visit to discuss a clinical trial opportunity with myself or my partner, to see if the patient would be interested and if they would be a good fit.

Nicole Fitzgerald: Because I was diagnosed so quickly before my husband and I had to make a big cross-country move, pulmonary hypertension was something obviously I had never heard of. It just was not even on my radar as something I should even know that this is something that could happen. I just had no idea that it even existed. I would say because we moved so soon after and I was consumed with trying to just find my footing in terms of the move, and then finding the right doctors in Oklahoma, because I had none when I came out here, there was a lot that I was learning to navigate. Obviously, it was a lot of change at once. For a long time, just trying to get myself with the right doctors, having all the right testing done, kind of getting a control on my medicines and what things I should take. Just getting myself stable took a very long time. 

The first year or so I would say was the most challenging, just because of all the newness and all the adjustments that were being made in my life in general, so it took a lot. I got worse before I got better. So, like I said, just getting stable I would say was my biggest priority for a very long time. It took a while before I started to hear from other patients that there were clinical trials available. Once those opportunities became available to me, that was something that I was very interested in, because I wanted to kind of be as aggressive as possible with treating my PH. 

Initially, that was not even on my radar. It was just more about getting myself to a point in my health where I was stable and can do normal things, which was a real big challenge for me, especially early on. So, it was primarily online through Facebook support groups for patients with PH. You kind of hear rumblings, just word of mouth of other patients were taking a particular trial, or participating here or there. Questions had been brought up with their physicians wherever they were from. 

You kind of branch out a little bit to know that there are trials taking place. It wasn’t something where I right away sought that out for myself. For me as a patient, I was just excited that research was being done. I think that’s something that all of us as patients just want to know, that there’s hope out there. I think we get kind of so bogged down in the drugs that we have available to us. There’s only so many and you are put on one thing, and you either respond to it well or you don’t, and then they take you off, and maybe you get put on something else depending on how you’re feeling. 

So, after a while you just kind of get kind of in that routine, but you want to know that there is hope coming, that there are better drugs coming, that there’s something else out there. So, I think as patients, we’re just all really excited and curious to know that there’s research being done, there’s trials being done. So, that was something exciting that I had heard about online, but it wasn’t anything necessarily specific where I right away brought that up to Dr. Kingrey. That was something that he brought up with me and I’m so happy he did. It worked out well for me in the end.

John Kingrey, MD: I think that one thing that’s really important for patients to understand, is that clinical trial work is really, really hard work. The ability to recruit patients for clinical trial takes a lot of effort in identifying the right patient population and identifying patients who are not excluded for a number of many reasons that patients can excluded from trials, and again that they have the right disease state. 

The next step is finding someone who is willing and open to the concept of a clinical trial. I think that there are a lot of people out there that look at clinical trials as a big risk. A phrase that I hear a lot and I know that other providers hear a lot is, patients say, “Well, am I going to be a Guinea pig?” That is kind of an antiquated way of looking at things, because the clinical trial space is so heavily regulated and protected, even in the hands of a provider who may not be paying it that close of attention to detail. It’s really, really hard to enroll a patient in a clinical trial and have them be subject to a real significant risk, that at least has not been properly spelled out. 

Many people don’t understand, for example, that when it gets to a phase of clinical trial where human beings are involved, that the medications or the devices, or whatever it might be have been trialed in both animal studies and also in healthy patients that don’t have the disease, just to demonstrate safety. That’s a barrier for some people. I think though, that probably the biggest barrier is the relationship that they have with their physician, because it doesn’t matter if I told a patient that I’ve got a clinical trial in Tylenol that’s been on the market for decades. If they don’t trust me and they don’t have a relationship with me, it’s unlikely that that person’s going to want to be part of a clinical trial.

There’s two reasons generally that people end up doing a clinical trial. One is that they look at the potential benefit for their own health, which of course is a huge reason that it exists. The other is because that patient really wants to benefit others who may come after them, who will be suffering from a similar disease and now potentially have a new therapy, because of the way that was laid forward by clinical trial participants. 

The most important thing that I would say to patients and also to physicians, is if you want to be involved in a clinical trial, and from my standpoint, if you want your patients to be involved, you better know your patients. You better know more than just what’s in black and white. You better have a relationship with them. And if you don’t, it’s going to be really, really hard to bring up a clinical trial that’s going to potentially come across as very scary and very experimental, when in reality there’s a lot of protection built into clinical trials, particularly in the United States, that is squarely focused on protecting the patient.

Another element in considering clinical trial participation is making sure that the clinical trial is going to fit within the signature that the patient needs. Another way of saying that is, consideration of participation in clinical trials is really important to tailor the needs of the patient and ensure that the clinical trial fits within the boundaries of what would be an individualized treatment plan. In pulmonary hypertension, for example, we do have some guidelines regarding treatment and how patients should generally be approached. However, it is not cookie cutter. There are several different pathways that patients can go down and arrive at a good outcome, but the considerations of how to get there are variable. They would include patient’s preferences on how they take medicines, patient’s tolerance of certain side effects that certain classes of medications have, the amount of pills that someone needs to take and so forth.

So in clinical trial, the point here is, every patient has a very individualized treatment plan, and when we think about what the next thing is that the patient needs, we have to ask ourselves, does any of the clinical trials that I’m offering, assuming that the patient fits the general profile, is that going to be beneficial to them? 

So, severity of disease is interesting, because some clinical trials exclude patients who are doing too well, others exclude patients who are too sick. You have to be able to take that into account, as to whether or not the medication or the certain application of a medication is handled. We have to be incredibly prescriptive in identifying the right type of patient for the right clinical trial. 

Another element of this is helping the patient understand where the potential treatment comes into play. Many times, I will have a patient, for example, that comes to me and is doing worse. If I have a clinical trial that that patient would fit, but that particular clinical trial has a study design that is very common, where neither myself nor the patient know if they’re going to get the medication, meaning that it’s placebo-blinded, so it’s a double-blinded placebo trial, and I know that that patient needs more therapy, I don’t feel like it would be ethical. If I have something else to use that I know would help them that would be already on the market, then I’m not going to have that patient be in a clinical trial, where they could be going six or 12 months without getting anything. Or even if they did get the medicine, something that’s clearly under investigation, when I could be reaching into the cupboard and grabbing a medicine that is already available that I know would be immediately beneficial. 

There are a lot of considerations. That’s just one example. Other things would include patients access to coming to a clinical trial. In Oklahoma City, we have many patients who live hours away from us, and though clinical trials are incredibly good about making sure that the patient doesn’t have out-of-pocket costs for things like travel, it still can be a matter of time not available or reasonable for the patient to do it, because of travel time or perhaps they work and they wouldn’t be able to get off work. So there’s lots of things that have to be under consideration before somebody really is able to fit in a clinical trial.

Nicole Fitzgerald: For me, I think a lot of consideration, obviously, was given to my health at the time. During that period, I was a little bit more stable, but not as good as I had been or as I could be. So, it was one of those things where I just kind of fit into a category where it was like, okay, well, I’m not super sick. I’m not as sick as I was initially when I was diagnosed and at various times had been, but I’m also not feeling great. I’m not feeling at my very best. I’m sure I could be doing better. So, it was one of those things where it was like, okay, well, I’m just kind of at a standstill, but not at a place where I am necessarily as good as I want to be. For me, it was obviously interesting to have something that could help me more than I was being helped already.

Then, there’s also, as Dr. Kingrey mentioned earlier, you’re in a position where you want to help yourself, but then there’s also that feeling of, okay, well I can do something potentially that can help a lot of other patients. So for me, that’s obviously always a factor. There’s a lot of things that get taken into consideration when you want to participate in a trial. Obviously, you have to meet the criteria of whatever trial you’re participating in.

There’s things that involve just your own personal lifestyle, the way that you might administer the medication, how often the trial visits are, Like he mentioned, Oklahoma City, there’s people that live pretty far out. I am fortunate that I live only 20 minutes away from the center where all my trial visits are, so it’s convenient for me, as opposed to other people might have a lot more difficulty just getting back and forth. There are lots of things that factor in, but for me it seemed like it would be a good fit and the time constraints weren’t anything extraordinary. So, it just worked out where I felt like, okay, this is something that could really benefit me, but also potentially help others down the road.

John Kingrey, MD: Once a patient is identified as a potential candidate for a clinical trial, that’s just the beginning. Usually the next step is, I will have a conversation with the patient about the opportunity to participate in a clinical trial. With that, will be a general overview of the type of patient that the clinical trial is looking for, which obviously the patient you’re talking to should fit that. Then, I will give an overview of what the general purpose of the trial is and how it’s constructed, in very high level terms, not getting into the nitty-gritty at that point, but just to explain generally what we’re doing. 

The next thing that I do is if the patient has interest, then, I will talk to my clinical trial coordinator and they will give the patient a phone call. Or, if the coordinator is available, I’ll have them come down to the clinic right there in real time, if both the coordinator and the patient has the time. Either way, there’s a conversation that takes place between the clinical trial coordinator and the patient that involves additional detail to kind of put a little bit more meat on the bones, so to speak. At that point, the patient says, “Yes, I’m really interested in this.”

Then, typically the clinical trial coordinator will go through exclusion and inclusion criteria to make sure that the patient is the right fit. Sometimes that happens independently. Sometimes the clinical trial coordinator will have questions, and they will come to me and we’ll make sure that yes, the patient is the right fit. Once we’ve cleared that step and there isn’t anything obvious, then, starts the process of an official screening. Screening is when the patient comes in and provides consent to participate in the clinical trial. Then, a series of tests and questions happen to make sure that there isn’t anything else right before the patient would go into the clinical trial that would potentially exclude them.

The cool thing is, is that patients with pulmonary hypertension are not going to be unfamiliar with most of what is required. Every trial is different, but most trials are going to have some combination of requiring a six-minute walk, lung function tests, imaging, sometimes a CT scan, sometimes perhaps an MRI, chest x-ray. Some clinical trials will require a repeat heart catheterization within a certain period of time of enrolling in the clinical trial. Not all of them. Some of them just want to demonstrate that at some point, yes, the patient was properly diagnosed with pulmonary hypertension of whatever variety the study is looking at. Always blood work and then a questionnaire. Now, that is not necessarily a comprehensive list. There could be a few other things, but it’s pretty rare that there’s something that the patient has never heard of before that needs to be done as part of a clinical trial evaluation for pulmonary hypertension, because most of what we’re looking at are things that we’re already doing in the evaluation of a patient.

Once you go through all of that, it’s kind of like a final system of checks and balances. Okay, we did the screening testing, everything seems to be checked out, and yep, you are a go. Everything is good. There’s nothing that has excluded you. You’re exactly the right patient. Once you clear that hurdle, then the patient becomes enrolled officially in the clinical trial. Of course, at that point, it depends on how the trial is designed. There could be a medication involved or perhaps a different application of a known medication, perhaps a device or something that the patient will need to have with them, or inserted or whatever. There’s lots of different possibilities, but that process of screening really starts well before an official screening. Then, you go through the testing to make sure that everything still checks out. 

Then, you go through the clinical trial. Clinical trials are of various duration. Usually in pulmonary hypertension, it’s a pretty common interval is usually at least six months. There have been certainly clinical trials that have lasted shorter than that. There are some that go beyond that. Obviously, the patient is going to know that before they would ever even sign consent, what the duration of the trial is. So, you go through the clinical trial. 

At the end of the investigation period, many clinical trials then have an opportunity to go into what’s called an open label extension. If it’s a drug trial and the drug is not approved on the market yet, then the only way to get access to the medication is within the confines of a clinical trial. So the cool thing is, and it’s really kind of a fringe benefit of participating in the clinical trial, is the patient many times, and the patient would know this before entering the trial if this were an option, it’s not held out as a mystery until you get done with the trial period. So let’s say the trial is six months. At the end of the six months, you and the physician are unaware if you’ve got the drug, if it was a drug trial, for example. At the end of the six months, many clinical trials are structured so that you can enter into an open label extension, which means the patient is guaranteed to get the drug, not a placebo, but the actual drug, for a period of time that could go on for even years.

Again, that’s something that is spelled out in advance, because even at the end of a clinical trial, it’s not like, oh, you enroll all the people and then a few days later you go to the Food and Drug Administration and they say, “Okay, good job. We’ll let it go,” and you can put the drug on the market. It’s much more complicated than that, and time is measured in years on these sorts of things before the drug may potentially be available to the public. 

Nicole, in the clinical trial that she participated in, she’s still getting a medication that is not available to anybody in the public. A doctor can’t go and just prescribe this medication, and she could very well be on it for several years before the medication is ultimately approved by the Food and Drug Administration. Or, if the trial showed that there was not benefit to it, then she would go off it at that point too.

Nicole Fitzgerald: I knew going in if for some reason I was not responding well to the drug or if it just didn’t fit in time-wise for any reason at all that I wanted to leave, that I was able to do so. That was something that was made very clear from the beginning. I really just want to stress, I know that there’s a lot of apprehension from some patients, that maybe they feel like they are going to be a Guinea pig in participating, or maybe they don’t have a lot of trust within their doctor-patient relationship, or they might’ve heard anecdotal stories about someone that had a bad experience in a trial. I have felt nothing but respect from the people that ran the clinical trial that I am participating in. Every single person has been very respectful of me, of my time, of my participation. They have really gone out of their way to make sure that appointments run as smoothly as possible, as efficiently as possible, so that my time and their time isn’t wasted. And just that all around, I have a good experience.

I have been really, really fortunate in that respect, and I think that that is more common than the other experience, which is obviously anecdotal that people have heard, that is not a good experience and they feel like they’re doing this and not really getting anywhere, or not hearing anything and maybe feeling somehow exploited. That is not at all what I have experienced. 

When I was first looking for clinical trials, I had to do some legwork of my own. I had heard about certain trials that were out there and I went online. I went to www.clinicaltrials.gov. I looked around to see what would be available for me, if there was anything in my area that I could participate in.

It turns out that the trial I had initially been looking into and was hopeful I could participate in, that wasn’t available to me, but I ended up in another trial instead. I was a participant in the TORREY study, and that worked out really well for me. I also just want to say one of the great benefits obviously, aside from having early access to a drug that may get approved down the road is, all the testing that is required is all covered by the trial. So, all of the blood work that I have done and the extra tests that are involved, including right heart cath, all of that that I have had done is all paid for by the trial. So, I kind of feel lucky that I’ve had all of this extra testing that hasn’t been charged to my insurance. I’m appreciative of that, so that’s an added benefit as well.

John Kingrey, MD: Clinical trial work is really, really exciting. It’s exciting for the patient, because it’s an opportunity to have exposure to frontier medicine, meaning the latest and greatest of what’s out there. It’s giving a patient access to care and access to therapies that they wouldn’t have in any other way. That’s probably the single greatest element of doing clinical trial. As a physician, it’s really exciting, because we get to be part of that and to learn, along with the patients, about the new therapies that are being investigated. Along this path, I can tell you that some of the unanticipated things that happen is, from a physician perspective, is you get to know your patient a lot better. You’re seeing them more frequently, you get to talk to them more frequently. You are asking of course about things that are relevant to not only the clinical trial, but the other symptoms or problems they may be having. So, you get a lot more face time with your patients and the patients get more face time with you, which I think is mutually beneficial.

The other thing is, is that I think patients realize when they participate in clinical trials, I can only talk about pulmonary hypertension, because I haven’t been knee-deep in clinical trials in any other disease state. But the pulmonary hypertension community is so tight and so committed to helping patients, that the patients really get to catch the spirit of not only what’s going on in their own body, but what’s going on in the entire pulmonary hypertension community globally, what’s happening to try to move the disease forward.

That’s really exciting. I think that’s really exciting for patients to be able to be a part of that, because you’re literally creating history. You are laying the groundwork for generations to come. Even if the drug doesn’t work or whatever’s being investigated doesn’t work, that’s really helpful information. Patients are like, “Well, what if this doesn’t turn out?” Well, you know what? That’s also beneficial, because generally in medicine, you have to have a lot more failures before you nail the successes, and that’s certainly the case in pulmonary hypertension, something that we see. Of course, we hope that that’s not the case. The only way to find out is through the clinical trial space.

I also think that patients understand that the sponsors of the trials are so committed to helping these patients get access to care. The other thing is, is that I think my patients feel it from the sponsor and from the people who are administering the clinical trials, that these people actually really care, and they’re really invested in trying to make things better. I think what that does is that takes you beyond from just being a patient and you really catch the spirit of what pulmonary hypertension is really all about. I’d like to thank you all for listening. My name is Dr. John Kingrey.

Nicole Fitzgerald: And I’m Nicole Fitzgerald, and I’m aware that I’m rare.

Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Follow us on instagram, facebook and x.com @phaware. Engage for a cure: www.phaware.global/donate #phaware Share your story: info@phaware.com Like, Subscribe and Follow us: www.phawarepodcast.com.

Listen and View more on the official phaware™ podcast site

[cardiologistdrfarhanshikoh]

Understanding Valve Disorders: What Are They?

The human heart has four vital valves that ensure proper blood flow in the right direction. These valves can sometimes become dysfunctional, leading to what is known as a valve disorder. Valve disorders may involve narrowing (stenosis), leakage (regurgitation), or improper closure, which can cause various heart-related symptoms.

1. Mitral Valve: Located between the left atrium and the left ventricle, the mitral valve controls the flow of blood from the left atrium to the left ventricle. Mitral valve disorders can lead to shortness of breath, fatigue, and irregular heartbeats.

2. Aortic Valve: The aortic valve is situated between the left ventricle and the aorta, which is the largest artery in the body. Aortic valve disorders can restrict blood flow to the body, leading to chest pain, fainting, or heart failure if untreated.

3. Tricuspid Valve: This valve is located between the right atrium and right ventricle. It ensures proper blood flow to the lungs. Issues with the tricuspid valve can result in swelling of the legs, abdomen, and liver.

4. Pulmonary Valve: Found between the right ventricle and pulmonary artery, the pulmonary valve manages blood flow to the lungs. Pulmonary valve disorders can cause symptoms like fatigue and shortness of breath.

If you are experiencing symptoms such as shortness of breath, fatigue, chest pain, or fainting, it might be time to consult a heart specialist.

For expert advice and consultation, visit Dr. Md. Farhan Shikoh, MBBS, MD (Medicine), DM (Cardiology) at Sukoon Heart Care, Sainik Market, Main Road, Ranchi, Jharkhand: 834001. You can also contact him at 6200784486 or visit drfarhancardiologist.com.

[sufrgery1]

Best Pulmonologist Doctors in Hyderabad -TX Hospitals

When it comes to respiratory health, consulting a skilled pulmonologist is crucial for accurate diagnosis, treatment, and management of various lung conditions. In Hyderabad, a city renowned for its advanced healthcare facilities, several pulmonologists stand out for their expertise and commitment to patient care. This article highlights some of the best pulmonologist doctors in Hyderabad, their qualifications, specialties, and the importance of timely intervention in respiratory health.

Importance of Visiting a Pulmonologist

Pulmonologists are medical specialists focused on the respiratory system, dealing with diseases that affect the lungs and breathing. If you are experiencing symptoms such as chronic cough, wheezing, shortness of breath, or frequent respiratory infections, seeking help from a pulmonologist is essential. These specialists conduct comprehensive evaluations, which may include pulmonary function tests, imaging studies, and bronchoscopy, to identify underlying conditions and develop effective treatment plans.

Top Pulmonologist Doctors in Hyderabad

1. Dr. B. Vijay Bhaskar

Dr. B. Vijay Bhaskar is widely regarded as one of the best pulmonologists in Hyderabad. He holds an MBBS, an MD in General Medicine, and a DM in Pulmonary Medicine. Dr. Bhaskar’s extensive experience and expertise allow him to effectively manage a wide range of respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and lung infections. His patient-centric approach, combined with advanced treatment methods, makes him a preferred choice for individuals seeking respiratory care.

2. Dr. Naresh Dude

With an impressive academic background that includes an MBBS, DNB, and FCCM, Dr. Naresh Dude specializes in pulmonary medicine and critical care. He is particularly known for managing complex cases of respiratory failure and severe lung diseases. Dr. Dude's commitment to providing high-quality care, along with his compassionate approach, has earned him a reputation as one of the top pulmonologists in Hyderabad.

3. Dr. Rohith Reddy

Dr. Rohith Reddy is a distinguished lungs specialist with an MBBS and MD in Pulmonary Medicine. He is dedicated to diagnosing and treating a variety of pulmonary disorders, including chronic respiratory diseases and sleep apnea. Dr. Reddy’s thorough evaluations and personalized treatment plans ensure that his patients receive optimal care tailored to their unique health needs.

4. Dr. Sathish Pogula

Dr. Sathish Pogula is a well-respected chest specialist with an MBBS, MD, and IDCCM certification. His expertise covers a broad spectrum of chest-related conditions, from common infections to chronic lung diseases. Dr. Pogula’s focus on early diagnosis and intervention helps patients manage their conditions effectively and improve their overall respiratory health.

5. Dr. M.V. Sree Keerthi

As a leading pulmonologist, Dr. M.V. Sree Keerthi holds an MBBS, DNB, and DTCD in Pulmonology. He is known for his commitment to treating various lung conditions while emphasizing preventive care and patient education. Dr. Keerthi's holistic approach to patient management helps individuals understand their health better and empowers them to take control of their respiratory well-being.

6. Dr. M. Sai Sashank

Dr. M. Sai Sashank is a prominent pulmonary specialist with an MBBS and MD. He is known for diagnosing and treating both common and complex pulmonary diseases. Dr. Sashank adopts a comprehensive approach to treatment, incorporating medical interventions alongside lifestyle modifications to enhance patient outcomes.

Services Offered by Pulmonologists

Pulmonologists provide a wide range of services, including:

Diagnosis and Treatment: Comprehensive evaluation and management of respiratory diseases such as asthma, COPD, and lung infections.

Pulmonary Function Tests: Detailed assessments of lung capacity and function to aid in diagnosis.

Bronchoscopy: A minimally invasive procedure for visualizing the airways and diagnosing lung conditions.

Sleep Studies: Evaluations for sleep-related breathing disorders like sleep apnea.

Management of Chronic Conditions: Ongoing care for chronic respiratory diseases, focusing on improving quality of life.

Conclusion

If you are experiencing respiratory issues or require specialized care for lung conditions, consulting one of the best pulmonologist doctors in Hyderabad is essential. With their extensive training and dedication to patient care, these specialists are well-equipped to provide effective diagnosis and treatment options tailored to your needs.

For more information or to schedule an appointment with a top pulmonologist in Hyderabad, contact TX Hospitals at 9089489089. Taking charge of your respiratory health is vital, and a visit to a qualified pulmonologist can lead you toward a healthier and more fulfilling life.

[social-book]

Top Pneumonia Specialists in Hyderabad: Expert Care at TX Hospitals

Introduction;

Pneumonia is a serious respiratory condition that requires prompt and effective treatment. At TX Hospitals, we are committed to providing expert care through our team of highly qualified pneumonia specialist in Hyderabad. Our goal is to ensure that you receive the best possible treatment to manage and overcome this challenging condition.

Why Choose TX Hospitals for Pneumonia Care?

Expert Specialists

Our pneumonia specialists at TX Hospitals are among the most experienced in Hyderabad. They possess extensive training and knowledge in diagnosing and treating pneumonia and related respiratory conditions. Each specialist is dedicated to providing personalized care and utilizing the latest advancements in medical science to achieve the best outcomes.

Comprehensive Diagnosis and Treatment

At TX Hospitals, we offer a comprehensive range of diagnostic and treatment services for pneumonia. From initial evaluation to advanced treatment options, our team is equipped to handle all aspects of pneumonia care. We use state-of-the-art diagnostic tools to accurately identify the type and severity of pneumonia, ensuring that you receive the most effective treatment plan.

State-of-the-Art Facilities

Our hospital is equipped with advanced facilities and cutting-edge technology to support accurate diagnosis and treatment. Our imaging and laboratory services are designed to provide detailed insights into your respiratory health, enabling our specialists to make informed decisions and tailor treatment to your specific needs.

Patient-Centric Approach

We prioritize your comfort and well-being throughout your treatment journey. Our pneumonia specialists work closely with you to develop a personalized care plan that addresses your unique needs and concerns. We believe in a patient-centric approach that involves you in the decision-making process and ensures that you are informed and supported every step of the way.

Meet Our Pneumonia Specialists

Dr. B. Vijay Bhaskar – Leading Pneumonia Specialist

Dr. B. Vijay Bhaskar is a highly respected pulmonologist with extensive expertise in treating pneumonia. With an MBBS, MD in General Medicine, and a DM in Pulmonary Medicine, Dr. Bhaskar is well-versed in managing complex respiratory conditions and providing effective treatment for pneumonia.

Dr. Naresh Dude – Expert in Pneumonia Care

Dr. Naresh Dude is known for his exceptional skills in pulmonary medicine and critical care. Holding an MBBS, DNB, and FCCM, Dr. Dude brings a wealth of experience to the treatment of pneumonia. His comprehensive approach to patient care ensures that you receive the highest quality treatment.

Dr. Rohith Reddy – Specialized Pneumonia Treatment

Dr. Rohith Reddy, with an MBBS and MD in Pulmonary Medicine, is a leading specialist in pneumonia care. His expertise in diagnosing and treating various forms of pneumonia ensures that you receive accurate and effective care.

Dr. Sathish Pogula – Expert Chest Specialist

Dr. Sathish Pogula, with an MBBS, MD, and IDCCM, is a distinguished chest specialist with a focus on pneumonia and other respiratory conditions. His extensive knowledge and experience make him a valuable asset in managing pneumonia effectively.

Dr. M.V. Sree Keerthi – Specialist in Lung Health

Dr. M.V. Sree Keerthi, with an MBBS, DNB, and DTCD (Pulmonologist), is renowned for his expertise in lung health and pneumonia treatment. His patient-focused approach and advanced diagnostic skills contribute to successful outcomes for pneumonia patients. [Read More]

Dr. M. Sai Sashank – Pneumonia Care Specialist

Dr. M. Sai Sashank, with an MBBS and MD, is a skilled specialist in managing pneumonia and other respiratory conditions. His commitment to patient care and effective treatment strategies ensures that you receive the best possible care.

Book Your Appointment

If you are seeking expert care for pneumonia, TX Hospitals in Hyderabad is here to help. Book your appointment with one of our top pneumonia specialists by calling 9089 48 9089. Our team is ready to provide you with the highest quality care and support to help you recover and maintain optimal respiratory health.

Conclusion

Choosing the right specialist for pneumonia is crucial for effective treatment and recovery. At TX Hospitals in Hyderabad, our team of experienced pneumonia specialists is dedicated to providing exceptional care and support. Book now at 9089489089 and take the first step towards better respiratory health with our expert team.

For more information or to schedule your appointment, feel free to reach out to us. Your health and well-being are our top priorities, and we are here to ensure you receive the best care possible.

[covid-safer-hotties]

Also preserved on our archive

Some interesting science analyzed

BY BROOKS LEITNER

Imagine lying back in an enclosed chamber where you bask for 90 minutes in a sea of pure oxygen at pressures two to three times that felt at sea level. This is the world of hyperbaric oxygen therapy (HBOT), a technology that’s been around for decades and is now being explored as a possible treatment for Long COVID.

"The silence on the inside is deafening at first,” says John M.,* who has undergone dozens of HBOT treatments for his persistent Long COVID symptoms. Fortunately, there is a television outside the chamber in view, and it is easy to communicate with the provider if needed. While the potential protocol is still being refined, patients may undergo up to 40 HBOT sessions to address some of the most problematic, lingering symptoms of this complex condition.

HBOT is a therapeutic process that has been widely used to treat such conditions as decompression sickness in scuba divers, carbon monoxide poisoning, and diabetic foot ulcers. In HBOT, the body is exposed to 100% oxygen, a significant increase from the 21% oxygen concentration we typically breathe. The therapy takes place in an enclosed chamber where the air pressure is elevated above normal levels. The combination of high-pressure and high-oxygen conditions enhances the amount of oxygen that can reach the body's tissues. The hope is that this therapy can provide the same relief and healing to people with Long COVID that it does for those with other conditions.

According to John M., HBOT was the first treatment that helped with his sleep and reduced his heart palpitations. “At one point after hospitalization, my Long COVID symptoms were so bad that I could barely walk or talk. HBOT was a great tool that really assisted with my recovery,” he said. John added that he hopes the medical community will achieve a better understanding of how HBOT can help relieve suffering for patients with Long COVID and that more research will increase access to this innovative therapy.

Does HBOT improve Long COVID symptoms? One key observation from the work of Inderjit Singh, MBChB, an assistant professor at Yale School of Medicine (YSM) specializing in pulmonary, critical care, and sleep medicine, is that Long COVID patients often experience debilitating fatigue. Based on Dr. Singh’s previous Long COVID research, the exhaustion is thought to be linked to the muscles’ inability to efficiently extract and utilize oxygen.

To picture how HBOT might work, you can think of your muscles as engines sputtering, struggling to get the fuel they need. If oxygen is the gas that fuels the muscles, it’s as if you are trying to complete your daily routine while the gas tank is running on “empty.” By aiming to directly address this oxygen utilization impairment, HBOT may be a potential solution.

A systematic review by researchers at the China Medical University Hospital noted that HBOT could tackle another major factor in the Long COVID puzzle: oxidative stress. This relates to the body's struggle to maintain balance when harmful molecules, known as free radicals, run amok, causing chronic inflammation.

Research co-authored by Sandra K. Wainwright, MD, medical director of the Center for Hyperbaric Medicine and Wound Healing at Greenwich Hospital in Connecticut, suggests that HBOT, with its high-oxygen environment, might dampen this chronic inflammation by improving mitochondrial activity and decreasing production of harmful molecules. Other potential benefits of HBOT in the treatment of Long COVID may include restoration of oxygen to oxygen-starved tissues, reduced production of inflammatory cytokines, and increased mobilization of hematopoietic stem cells—primary cells that transform into red blood cells, white blood cells, and platelets.

HBOT for Long COVID: Current and ongoing research Several small-scale reports have indicated that HBOT is safe for patients with Long COVID.

To address this question, a trial that followed the gold standard of modern medical research—a randomized, placebo-controlled, double-blind design—assigned 73 Long COVID patients to either receive 40 sessions of HBOT or a placebo of only 21% oxygen. The study observed positive changes in attention, sleep quality, pain symptoms, and energy levels among participants receiving HBOT. In a longitudinal follow-up study published in Scientific Reports, the authors at the Tel Aviv University found that clinical improvements persisted even one year after the last HBOT session was concluded. In a second study, the same authors focused on heart function, measured by an echocardiogram, and found a significant reduction in heart strain, known as global longitudinal strain, in patients who received HBOT.

In another study, 10 patients with Long COVID underwent 10 HBOT treatments over 12 consecutive days. Testing showed statistically significant improvement in fatigue and cognitive function. Meanwhile, an ongoing trial at the Karolinska Institute in Sweden has reported interim safety results wherein almost half of the Long COVID patients in the trial reported cough or chest discomfort during treatment. However, it was unclear whether HBOT exacerbated this symptom or if this adverse effect was due to the effort of participation by patients suffering from more severe Long COVID symptoms.

Is HBOT currently available as a treatment for Long COVID? For HBOT to become a mainstream treatment option for Long COVID, several critical priorities must be addressed. First, there is currently no established method for tailoring HBOT dosages to individual patients, so researchers must learn more about the specific features or symptoms that indicate potential benefits from HBOT. At the same time, we need to identify factors that may be associated with any adverse outcomes of HBOT. And finally, it’s important to determine how long these potentially beneficial effects last in a larger cohort. Will just a few HBOT trials be enough to restore patients to their baseline health, or will HBOT become a recurring component of their annual treatment regimen?

For now, HBOT remains an experimental therapy—and as such is not covered by insurance. This is a huge issue for patients because the therapy is expensive. According to Dr. Wainwright, a six-week course of therapy can run around $60,000. That’s a lot to pay for a therapy that’s still being studied. In the current completed studies, different treatment frequencies and intensities have been used, but it’s unclear how the treatment conditions affect the patient’s outcome.

“I have had some patients notice improvements after only 10 or 15 treatments, whereas some others need up to 45 treatments before they notice a difference,” notes Dr. Wainwright. “I think that HBOT is offering some promising results in many patients, but it is probably a strong adjunctive treatment to the other spectrum of things Long COVID patients should be doing, like participating in an exercise, rehab, and nutritional program.”

Dr. Singh notes that “a major challenge for research is the heterogeneity of Long COVID. It is hard to determine which symptoms to treat and enroll patients into trials based on them.”

Perhaps treatments that target multiple issues caused by Long COVID, like HBOT, may help overcome this challenge.

*Not his real name.

Brooks Leitner is an MD/PhD candidate at Yale School of Medicine.

The last word from Lisa Sanders, MD: Hyperbaric oxygen therapy (HBOT) is just one of the many existing treatments that are being looked at to treat Long COVID. We see this with many new diseases—trying to use a treatment that is effective in one set of diseases to treat another. And there is reason for optimism: We know that HBOT can deliver high levels of oxygen to tissues in need of oxygen. That’s why it’s used to treat soft tissue wounds. If reduced oxygen uptake is the cause of the devastating fatigue caused by Long COVID, as is suggested by many studies, then perhaps a better delivery system will help at least some patients.

Studies referenced:

bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08002-8

www.ncbi.nlm.nih.gov/pmc/articles/PMC8806311/

www.nature.com/articles/s41598-024-53091-3

www.nature.com/articles/s41598-022-15565-0

www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1354088/full

www.ncbi.nlm.nih.gov/pmc/articles/PMC11051078/#:~:text=Proposed%20Mechanism%20of%20HBOT%20o

[larajenish]

    Who is a Pulmonologist?

A pulmonologist is a medical doctor who has completed extensive training in internal medicine and then pursued further specialization in pulmonology, which is a branch of medicine focused on the respiratory system.

After finishing medical school, they typically undergo a three-year internal medicine residency followed by a two- to three-year fellowship in pulmonology. This specialized training equips the best pulmonologist in Chennai with the expertise to diagnose, manage, and treat a variety of respiratory disorders.

Conditions Treated by Pulmonologists

The top pulmonologist in Chennai manages a broad range of respiratory conditions, ranging from acute to chronic and mild to life-threatening. 

Asthma: A chronic condition that usually causes inflammation and narrowing of the airways that leads to difficulty in breathing and wheezing.

Chronic Obstructive Pulmonary Disease (COPD): A group of progressive lung diseases, including chronic bronchitis and emphysema, which impairs airflow and makes breathing difficult.

Pneumonia: This infection has to be treated by a pulmonologist doctor in Chennai as it inflames the air sacs in one or both lungs, leading to symptoms such as cough, fever, and difficulty breathing.

Pulmonary Fibrosis: This condition is treated by the best pulmonologist in Chennai as it is characterized by scarring and stiffening of the lung tissue, which can lead to reduced lung function and breathlessness.

Lung Cancer: A malignant growth in the lungs that can spread to other parts of the body.

Pulmonary Embolism: A potentially life-threatening condition where a blood clot blocks a pulmonary artery, reducing blood flow to the lungs.

Sleep Apnea: A sleep disorder in which breathing stops repeatedly and starts during sleep. This leads to poor sleep quality and daytime fatigue.

Interstitial Lung Diseases: A group of disorders that cause inflammation and scarring in the interstitial spaces of the lungs.

When to Approach a Pulmonologist?

Individuals experiencing respiratory symptoms or diagnosed with a respiratory condition should consider consulting a top pulmonologist in Chennai. Common signs that warrant a visit to a pulmonologist include:

1. Persistent Cough: A chronic cough that lasts for several weeks or produces blood or colored mucus.

2. Wheezing: A high-pitched whistling sound while breathing.

3. Chest Pain: Chest discomfort or pain should be addressed by the best pulmonologist in Chennai as it worsens with breathing.

4. Chronic Respiratory Conditions: Known conditions such as asthma, COPD, or pulmonary fibrosis that require ongoing management.

5. Smoking or Exposure to Lung Irritants: Individuals with a history of smoking or occupational exposure to lung irritants should be monitored regularly by the pulmonologist doctor in Chennai.

Diagnostic Tests and Procedures

To diagnose respiratory conditions accurately, the best pulmonologist in Chennai uses various tests and procedures, including:

Pulmonary Function Tests (PFTs): These measure lung capacity and airflow to assess lung function and diagnose conditions like asthma and COPD.

Chest X-ray and CT Scan: Imaging tests are used by the pulmonologist doctor in Chennai to visualize the lungs and identify abnormalities such as tumors, infections, or pneumothorax.

Bronchoscopy: A procedure where a thin, flexible tube with a camera is inserted through the nose or mouth to view the airways and collect samples for biopsy.

Pulse Oximetry: Measures the oxygen saturation in the blood to assess lung function and oxygen levels.

Arterial Blood Gas (ABG) Test: This is used by the best pulmonologist in Chennai to measure the levels of oxygen and carbon dioxide in the blood to evaluate respiratory efficiency.

Sleep Studies (Polysomnography): It is used to diagnose sleep-related breathing disorders like sleep apnea.

The Best Pulmonologist in Chennai

Dr. L. Muthu Kumaran (MBBS, MD)

Dr. L. Muthukumaran is a pulmonologist based in Chennai, affiliated with Orthomed Hospital. Specializing in asthma, tuberculosis, pneumonia, and emphysema, this top pulmonologist in Chennai prioritizes patient care and continuously enhances his expertise through attending conferences and workshops. 

His dedication to staying abreast of the latest treatment technologies reflects in his practice. Moreover, he takes pride in being an active member of multiple esteemed associations and societies within the field of Pulmonology, ensuring he delivers the best possible care to his patients.

Treatment Plans by Pulmonologists Doctors

Pulmonologists, specializing in respiratory health, develop comprehensive treatment plans for various pulmonary conditions. Common interventions include prescribing inhalers or medications to manage respiratory symptoms like asthma or chronic obstructive pulmonary disease (COPD). Pulmonary doctors may recommend oxygen therapy for patients with low blood oxygen levels.

They also devise personalized strategies for smoking cessation and offer interventions for lung infections. Advanced treatments, such as bronchoscopy or pulmonary rehabilitation, are employed when needed. Pulmonologists collaborate with patients to create holistic plans that often include lifestyle modifications and ongoing monitoring to ensure optimal respiratory function and overall well-being.

Conclusion

To conclude, the best pulmonologist in Chennai plays a critical role in diagnosing and treating respiratory conditions, ensuring patients can breathe comfortably and maintain a good quality of life. If you or someone you know is experiencing respiratory symptoms or has a chronic respiratory condition, seeking the expertise of a pulmonologist at Orthomed Hospital can help you in the early detection and prevention of potential respiratory issues.

[eceozen]

Ece Ozen - A Compassionate Physician

Dr. Ece Ozen graduated from Mustafa Kemal University and completed rotations at MD Anderson, Memorial Sloan Kettering, and Cleveland Clinic. She finished her internal medicine residency at Ascension Saint Joseph Hospital in 2023. Passionate about pulmonary/critical care, she has published COVID-19 research and enjoys traveling and outdoor sports.

[txhospitals12345]

Pneumonia Specialist Doctor in Hyderabad: Expert Care at TX Hospitals

Pneumonia is a serious respiratory infection that affects the lungs, making it difficult to breathe. It can be caused by bacteria, viruses, fungi, or other pathogens, and can range from mild to severe. In some cases, pneumonia can be life-threatening, especially in older adults, young children, and people with weakened immune systems. Therefore, it is crucial to seek expert medical attention from a pneumonia specialist to ensure proper diagnosis and treatment.

In Hyderabad, there are numerous pulmonologists and respiratory specialists who are highly skilled in diagnosing and treating pneumonia. TX Hospitals, one of the leading healthcare providers in the city, is home to some of the best pneumonia specialists who offer comprehensive care and advanced treatment for all types of pneumonia.

Why Choose a Pneumonia Specialist?

Pneumonia specialists, or pulmonologists, are trained to deal with complex lung diseases and respiratory infections. A specialist can offer the best care for pneumonia by:

Diagnosing the Type of Pneumonia: Pneumonia can be caused by various pathogens, including bacteria, viruses, fungi, and even aspiration. A pneumonia specialist uses advanced diagnostic tools, such as chest X-rays, CT scans, blood tests, and sputum cultures, to determine the type of pneumonia and develop the most effective treatment plan.

Offering Targeted Treatment: Depending on the severity of pneumonia, treatment may involve antibiotics, antivirals, antifungals, or supportive care such as oxygen therapy. Specialists tailor treatment to each patient's needs and monitor progress to prevent complications.

Managing Complications: In severe cases, pneumonia can lead to complications like pleural effusion (fluid around the lungs), sepsis, or respiratory failure. Pneumonia specialists are skilled at recognizing and managing such complications promptly.

Preventive Care and Education: A pneumonia specialist also provides education on how to prevent pneumonia, especially for people at higher risk. This may include vaccination (like the flu shot and pneumococcal vaccine), proper hygiene practices, and lifestyle changes to support lung health.

Top Pneumonia Specialists in Hyderabad

Here are some of the leading pneumonia specialists in Hyderabad who are highly qualified and experienced in treating pneumonia:

Dr. B. Vijay Bhaskar – Pulmonologist and Respiratory Specialist

Dr. B. Vijay Bhaskar is one of the best pulmonologists in Hyderabad with an MBBS, MD in General Medicine, and a DM in Pulmonary Medicine. He has extensive experience in treating various lung diseases, including pneumonia. Dr. Bhaskar takes a holistic approach to patient care, diagnosing the underlying cause of pneumonia and offering the most appropriate treatments for rapid recovery. His expertise in managing severe cases and chronic respiratory diseases makes him a trusted specialist for pneumonia care.

Dr. Naresh Dude – Pulmonologist with Expertise in Respiratory Infections

Dr. Naresh Dude, with his qualifications including an MBBS, DNB, and FCCM (Fellowship in Critical Care Medicine), is highly regarded for his expertise in treating critical respiratory conditions, including pneumonia. He is skilled in managing severe cases that require intensive care and close monitoring. Dr. Dude’s dedication to providing high-quality care ensures that patients receive optimal treatment during their recovery.

Dr. M.V. Sree Keerthi – Specialist in Tuberculosis and Pulmonary Diseases

Dr. M.V. Sree Keerthi is an experienced pulmonologist who specializes in treating tuberculosis and other pulmonary diseases like pneumonia. With an MBBS, DNB, and DTCD (Diploma in Tuberculosis and Chest Diseases), Dr. Sree Keerthi provides comprehensive care for pneumonia, helping patients recover and manage the long-term effects of the disease. Her expertise in respiratory diseases makes her one of the top specialists in the city.

Dr. Sathish Pogula – Chest Specialist with Critical Care Expertise

Dr. Sathish Pogula, with an MBBS, MD, and IDCCM (Indian Diploma in Critical Care Medicine), is a highly skilled chest specialist who specializes in treating respiratory infections, including pneumonia. With his extensive experience in critical care, Dr. Pogula is adept at managing severe pneumonia cases that require intensive treatment, ensuring that patients receive the best possible care and recover without complications.

Dr. Rohith Reddy – Pulmonologist Focused on Respiratory Diseases

Dr. Rohith Reddy, an MBBS and MD in Pulmonary Medicine, is well-known for his expertise in treating lung diseases, including pneumonia. He provides specialized care for both acute and chronic respiratory conditions and uses advanced diagnostic tools to develop effective treatment plans. Dr. Reddy is dedicated to providing personalized care and ensuring patients make a full recovery from pneumonia.

TX Hospitals: The Best Place for Pneumonia Treatment in Hyderabad

TX Hospitals is one of the most trusted healthcare providers in Hyderabad, offering comprehensive services for treating pneumonia and other respiratory diseases. The hospital’s team of skilled pulmonologists, including experts like Dr. B. Vijay Bhaskar, Dr. Naresh Dude, and Dr. M.V. Sree Keerthi, provides top-quality care for patients with pneumonia.

TX Hospitals is equipped with the latest diagnostic and treatment technologies, enabling doctors to accurately diagnose the type of pneumonia and implement an effective treatment plan. The hospital’s ICU and critical care units are fully equipped to manage severe cases of pneumonia, ensuring that patients receive the best care possible.

For expert consultation and pneumonia treatment at TX Hospitals, call 9089489089 to book an appointment with one of the best pneumonia specialists in Hyderabad.

Contact TX Hospitals Today

If you or a loved one is experiencing symptoms of pneumonia, don’t wait for the condition to worsen. Contact TX Hospitals today at 9089489089 to schedule an appointment with a leading pneumonia specialist in Hyderabad. Early diagnosis and treatment are crucial for preventing complications and ensuring a speedy recovery. Let TX Hospitals provide the expert care you need for better lung health.

[diginerve]

MD in Physical Medicine and Rehabilitation: Scope & Salary

Are you interested in pursuing a career or becoming a doctor in the field of Physical Medicine and Rehabilitation? Well, the medicine MD course, which is created for postgraduate students, can help you achieve the career of your dreams.

But what exactly is PM&R? 

Let's have a look!

Physical Medicine & Rehabilitation (PM&R)

Known for its vast scope, this medical speciality is a branch that helps people of all ages with disabilities related to the neuromuscular-skeletal, cardiovascular, and pulmonary systems improve their abilities. In this field, different methods and therapies, such as exercise, medications, and medical devices, are used to help patients improve their abilities.

However, to become a competent physician, one must know complete details about this branch. Candidates must first pass their MBBS degree in order to specialize in MD in Physical Medicine. 

Career Options

Postgraduate students who want to learn about rehabilitation and restoration and pursue a career as physiatrists should definitely consider entering Medicine MD. 

The salary scope of these physicians can easily range from INR 6 lakhs to INR 12 lakhs per year, approx. This also means that the career scope for PM&R physicians is highly lucrative and promising as they play a keen role in helping patients overcome their disability-related medical conditions. 

Join DigiNerve: Best Medicine MD Course

To help students clear off their MD examinations, the experts of DigiNerve, Dr JyotirMoy Pal and Dr Shashank R Joshi, have diligently created the "Medicine MD Course."

The course aims to help students prepare for their final MD examinations. It is an e-course, which you can buy at your convenience and time slot. Besides that, here's what all you can get as soon as you enroll in this medicine MD course:

Video lectures: The 210+ hour medicine video lectures enable students to gain a better understanding and prepare for MD-level examinations. 

Lecture notes: With well-illustrated 310+ lecture notes, students can better understand each topic.

Animation videos: Some concepts might be complex because of the branches involved. This is why we have included 30+ animation videos that explain them in a simple way. 

Benchmark trials: To ensure that all the information in this e-course is updated, we have also added over 590 evidence-based studies and benchmark trials. 

Dr Wise AI Bot: This e-course includes an AI chatbot that will help clarify doubts and provide interactive solutions. 

Therefore, by enrolling in this course, you will open a pathway to becoming exceptional physicians who treat patients with mobility issues.

End Note

Those medical students who want to competently handle all the medical problems related to their field of PM&R must enroll in DigiNerve's Physical MD course. Enrolling in this course allows candidates to focus on different diagnoses and clinical methods that they can use to assist the problems of the patients once they turn into professional physicians. 

Also, this course is a must-buy because of the range of features incorporated into it, which will help students better prepare for their MD exams. 

So it's high time you took the right step towards your future!